Fibroblast growth factor receptors (FGFRs) and noncanonical partners in cancer signaling

HR Ferguson, MP Smith, C Francavilla - Cells, 2021 - mdpi.com
Increasing evidence indicates that success of targeted therapies in the treatment of cancer is
context-dependent and is influenced by a complex crosstalk between signaling pathways …

Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer

C Francavilla, CS O'Brien - Open Biology, 2022 - royalsocietypublishing.org
Fibroblast Growth Factor Receptor (FGFR) signalling plays a critical role in breast embryonal
development, tissue homeostasis, tumorigenesis and metastasis. FGFR, its numerous FGF …

Risk and prognostic factors of breast cancer with liver metastases

L Ji, L Cheng, X Zhu, Y Gao, L Fan, Z Wang - BMC cancer, 2021 - Springer
Background Liver metastasis is a significant adverse predictor of overall survival (OS)
among breast cancer patients. The purpose of this study was to determine the risk and …

Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer

J Sun, H Zhao, W Xu, GQ Jiang - Frontiers in Chemistry, 2022 - frontiersin.org
Breast cancer (BC) is one of the most common cancers in women worldwide; however, the
successful treatment of BC, especially triple-negative breast cancer (TNBC), remains a …

Identification of gender-specific molecular differences in glioblastoma (GBM) and low-grade glioma (LGG) by the analysis of large transcriptomic and epigenomic …

MT Khan, B Prajapati, S Lakhina, M Sharma… - Frontiers in …, 2021 - frontiersin.org
Differences in the incidence and outcome of glioma between males and females are well
known, being more striking for glioblastoma (GB) than low-grade glioma (LGG). The …

Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer

W Han, M Liu, D Han, AA Toure, M Li, A Besschetnova… - Molecular Therapy, 2022 - cell.com
The androgen receptor (AR) plays a pivotal role in driving prostate cancer (PCa)
development. However, when stimulated by high levels of androgens, AR can also function …

Identification of antisense and sense RNAs of intracrine fibroblast growth factor components as novel biomarkers in colorectal cancer and in silico studies for drug and …

L Rejali, E Nazemalhosseini-Mojarad, L Valle… - Environmental …, 2023 - Elsevier
Introduction Colorectal cancer (CRC) is one of the most malignant tumors and in which
various efforts for screening is inconclusive. The intracrine FGF panel, the non-tyrosine …

FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule‐stabilizing effect

H Yu, H Wang, A Qie, J Wang, Y Liu, G Gu… - Cancer …, 2021 - Wiley Online Library
Platinum‐based regimens are the most widely used chemotherapy regimens, but cancer
cells often develop resistance, which impedes therapy outcome for patients. Previous …

Progress: targeted therapy, immunotherapy, and new chemotherapy strategies in advanced triple-negative breast cancer

J Shi, F Liu, Y Song - Cancer Management and Research, 2020 - Taylor & Francis
Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast
cancer, accounting for approximately 15% of cases, and is defined by the lack of expression …

[HTML][HTML] Tumor-derived exosomal circular RNA Pinin induces FGF13 expression to promote colorectal cancer progression through miR-1225-5p

X Liao, T Li, L Yang, H Li, W Li, Y Liu, Z Xie - Gut and Liver, 2024 - pmc.ncbi.nlm.nih.gov
Background/Aims Colorectal cancer (CRC) is a common malignant tumor, and circular
RNAs (circRNAs) are abnormally expressed in CRC. However, the function and underlying …